This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

26 May 2011

Nestlé Acquires Prometheus Laboratories for $1.4 Billion

This acquisition is a strategic move into gastrointestinal diagnostics,' says Luis Cantarell, CEO of Nestlé Health Science.

The Swiss giant Nestlé has acquired San Diego-based Prometheus Laboratories, a diagnostics company, for a price estimated at more than $1.4 billion.


The buyout is all part of Nestlé's plans to develop "personalized nutrition strategies that will help in the management and prevention of chronic health conditions." That same strategy prompted Nestlé to buy Vitaflo, which works on metabolic disease treatments, as well as CM&D, which is active in IBD and cancer.

Related News